IP Library › Granted Patent US 8,865,155
Granted Patent B2
US 8,865,155 · App. 13/629,398 · Granted Oct 21, 2014

Patent

Inventors: Belinda Vallejo Galland (Sonora, MX); Aarón Fernando González Córdova (Sonora, MX); José Carlos Rodríguez Figueroa (Sonora, MX)
Assignees: Centro de Investigacion en Alimentacion y Desarrollo, A.C. (CIAD); Belinda Vallejo Galland; Aaron Fernando Gonzalez Cordova
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,155
App. No.
13/629,398
Granted
Oct 21, 2014
Kind
B2
Abstract

New Lactococcus lactis strains, NRRL B- 50571 and NRRL B- 50572 , and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.

Claims (8)

1. A method of lowering blood pressure in a hypertensive subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of a fermented milk or fermented milk-based product, wherein the product is made by fermenting a milk or milk-based starting material with Lactococcus lactis strain NRRL B-50571, and wherein the product comprises the polypeptides of SEQ ID NOS:1-18.

2. The method of claim 1 , further comprising the step of removing unhydrolyzed protein from the fermented milk or fermented milk-based product after the fermentation step.

3. The method of claim 1 , wherein the starting material is milk.

4. The method of claim 1 , wherein the starting material is a milk-based product.

5. A method of lowering low density lipoproteins (LDL) in the blood of a hypertensive subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of a fermented milk or fermented milk-based product, wherein the product is made by fermenting a milk or milk-based starting material with Lactococcus lactis strain NRRL B-50571, and wherein the product comprises the polypeptides of SEQ ID NOS:1-18.

6. The method of claim 5 , further comprising the step of removing unhydrolyzed protein from the fermented milk or fermented milk-based product after the fermentation step.

7. The method of claim 5 , wherein the starting material is milk.

8. The method of claim 5 , wherein the starting material is a milk-based product.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2013
From: RODRIGUEZ FIGUEROA, JOSE CARLOS
To: CENTRO DE INVESTIGACION EN ALIMENTACION Y DESARROLLO, A.C. (CIAD); GALLAND, BELINDA VALLEJO; GONZALEZ CORDOVA, AARON FERNANDO
Reel/Frame 030851/0202 →
Continuity (2)
Provisional Application 61540979 · Sep 29, 2011
Related Publication 20140154217A1 · Jun 5, 2014